Does flu vaccination work for children?

Flu season is upon us and with it the perennial question, should I get a flu shot. In 2006 the Advisory Committee on Immunization Practices (ACIP) extended its 2004 recommendation that children 6 months to 23 months be vaccinated (2 doses) to now include children 6 months to 59 months (<5 yyears old). I'm in a targeted group to get vaccinated (over 65 years) and my three grandchildren are in the targeted group for children (one will slide into the window during flu season). What do we know about the usefulness of getting vaccinated? It's been studied, but unfortunately the results are confusing. The latest confusing study to appear is from the New Vaccine Surveillance Network that CDC established in 1999 to look at exactly these kinds of questions. The Conclusions section in a just published paper says they were unable to demonstrate vaccine effectiveness in the 6 month to 59 month age group. That's not very good news, so we took a hard look at the paper and found much less there than appears in news summaries or even the paper's own abstract. After our own summary of the paper (it is available online so by all means make your own judgments if you have a vital interst in this) we'll let tell you what we are going to do and what what advice I have about our grandchildren, and what the advice is based on. First, the new study.

This is a hybrid design called a case - cohort study. It was designed to estimate the effectiveness of inactivated flu vaccine to prevent either inpatient (hospitalized) or outpatient (Emergency Room and doctor's office visits) flu-related events. It was carried out in three counties (around Rochester, NY; Memphis, Tennessee; and Cincinnati, Ohio) and compared how often laboratory confirmed cases of influenza were vaccinated with vaccination rates in children of the same age and at the same time who didn't have a flu-related event. If the vaccine works, we would expect the rate of immunization to be lower higher in the children that didn't have flu-related events compared to those that did. Since there were a variety of important differences within and between the groups, statistical methods were used to make it most likely the researchers were comparing like with like. In almost all the comparisons (between counties, age groups, types of insurance, etc.) the researches did in fact see that immunization rates were lower in the kids who got sick compared to the ones who didn't. This sounds very much like a demonstration that the vaccine was effective, something that has been shown in some other studies of the pediatric population as well. Yet the paper concludes:

Each year, US children aged 6 to 59 months experience high rates of hospitalizations, ED visits, and outpatient visits due to influenza. Despite this, we were unable across 3 large communities to demonstrate that influenza vaccination was effective in preventing influenza-related inpatient/ED visits or outpatient visits during 2 consecutive seasons (2003-2004 and 2004-2005) among 6- to 23-month-olds, 24- to 59-month-olds, or the entire age span. (Szilagyi et al., Arch Pediatr Adolesc Med. 2008;162(10):943-951)

In our view this is misleading. Examination of the paper itself reveals many reasons, all acknowledged by the authors, why the efficacy of vaccination might not have been as high in this population. They include the use of inactivated vaccine, thought to be less antigenic than live virus vaccines in children; known poor vaccine match in the years studies; uncertain but large potential biases in the inefficient case - cohort design, especially for accommodating bias from propensity of care seeking behavior; and relatively weak statistical power. The first three are inherent biases (systematic errors) but the last pertains to evaluation of random error. It simply is not true, examining the tables in this paper, to say that the data do not show vaccine efficacy. They in fact show better results for vaccinated children. But because the results are not "statistically significant," what remains in doubt is whether the apparent benefit of the vaccine is due to some random fluctuation one would get in choosing any sample from two groups who are otherwise the same (e.g., getting 6 heads and 4 tails in a coin flip ten times) or whether it is due to one of the biases just mentioned (although most of those effects would probably tend to mask effectiveness, not produce it) or whether it is due to the vaccine really being effective in preventing flu-related medical visits, or all three, perhaps pushing in different directions. This study is essentially non-informative of the main question. They tried hard. It is well done. They got it published. But it still didn't provide much information.

So what am I going to do, and why? I will, this year as in other years, get my flu vaccination. The data on whether it helps or not is a bit murky but I am betting it does. We know the vaccine raises neutralizing antibodies against influenza A virus and what we know about immunology suggests that affords protection. The cost of getting the flu is high. The risks of being vaccinated are quite low. For the same reasons I am going to advise the parents of my grandchildren to get them vaccinated. At least one was vaccinated last year, when he was 7 months old. When the one who is 3 months old gets to 6 months, in mid winter, I'll advise my daughter to get him vaccinated, too. Same for the almost 5 year old.

That's if the parents ask. I've discovered that while the world at large considers me an expert in these matters, my reputation doesn't extend to my nuclear family. At least they consider me harmless.

More like this

My children are no longer young. In fact they are old enough to have children of their own and when my daughter asked me if I thought her then 6 month old should get a flu shot I didn't hesitate: Absolutely, I said. And he did. Two of them, the required number. That was just before the flu season,…
One of the few predictable statistics in American public health is that between 35,000-40,000 people will die every year from 'ordinary' influenza. Most of these deaths are preventable. Yet we do nothing. In the U.S., influenza kills approximately the same number of people every year as breast…
I was catching up again on my favorite periodical (Morbidity and Mortality Weekly Report---the Dengue Fever story is Awe.Some.) I came across the official recommendations for Gardasil for males. Gardasil is the vaccine produced by Merck that can protect women against infection by four strains of…
It is decided. The Advisory Committee on Immunization Practices has met, ruminated, voted, and now decrees that pregnant women, health care workers, and children over six months old will be vaccinated first. The reason we even need to worry about this is that there will not be nearly enough flu…

The problem with these types of studies appears to be...that those children who were vaccinated may have come from familly situations that would make them less likely to contact influenza. As more persons are vaccinated and better studies are done, it seems the less effective the vaccine becomes.

It seems to me that:

1) due to the genetic instability which influenza has unbelievably learned to harness, the current technology does not work.

2) Vaccination in humans and animal-farm populations are assisting the speed of evolution of influenza and accelerating diversity.

3) due to 'original antigenic sin' (see wikipedia)...it may be possible that some individuals may be worse off after vaccination.

We need to continue to research new approaches to vaccine while we face facts about using chickens and eggs to produce vaccine against a disease that will in all likelyhood kill the chickens and eggs, introduced by workers at the facility during the asymptomatic incubation period of pandemic influenza (H5N1).

We need to provide stockpiles of off-patent and therefore economical solutions that do work....broad spectrum antibiotics, oral electrolytes, antifever and antishock oral medications and vaccines against secondary bacterial pneumonias.

Sometimes it takes humans a long time to get nature's messages.

If the vaccine works, we would expect the rate of immunization to be lower in the children that didn't have flu-related events compared to those that did

Do you mean higher?

caia: Of course I did. Mental lapse. Corrected. Thanks.

Revere: Thanks for your analysis on this important public health issue. I agree with Tom on many of his comments especially "sometimes it takes a long time to get nature's messages." Before we advocate the benefit of live attenuated flu vaccine (since one of the concerns is that inactivated flu vaccine may not be as antigenic as the live attenuated vaccine) to justify an annual mass vaccination campaign (especially for children), I feel that more investigations on a potential health risk linking flu virus and cancer are needed. A few weeks ago (9/29/08), I sent a comment and questions to DHH Secretary Mike Leavitt's Blog concerning the use of live attenuated flu vaccine as shown in the following excerpt:

"As you know, millions of Americans will get the flu shots including the live attenuated flu vaccine this year ahead of the flu season (typically from November to March). To err on the safe side, would it be important to investigate the presence or the lack of a potential cause-effect relationship between replication of influenza virus and cancer before millions of Americans may be at risk taking the live flu vaccine which contains live attenuated flu virus intended for limited replication in the host cells? In the short term, I believe that there are few experiments which may provide significant preliminary data quickly to help address this concern: Does replication of influenza virus (type A and/or B) directly or indirectly activate/increase (if any) the production of telomerase in human cells and for how long?"

As expected, neither Secretary Leavitt nor his office has posted any response to my inquiry regarding this potential health risk. Do you think we should ask the following questions: If there is a small possibility for this potential health risk to be true (hence we need supporting data to reject this concern), by administering a live attenuated flu virus to a large population (with the knowledge that not everybody will be infected naturally every year), are we going to see a rise in cancer rate over a long time because we fail to "get the nature's messages"? Does the benefit truly outweigh the risk? Is it more costly to care for a seasonal-flu patient than a cancer patient? Is it more likely for a flu patient to die than a cancer patient?

the latest ACIP recommendations call for shots for kids up to age 18. and the research to support this is....